← Back to Search

Corticosteroid

Dexamethasone for Tonsillar Bleeding (Blueberry Trial)

Phase 4
Waitlist Available
Research Sponsored by Walid HABRE
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 intervals: 0-2 hours, 2-6 hours and 6-24 hours postoperatively
Awards & highlights

Blueberry Trial Summary

This trial found that a single dose of Dexamethasone given during surgery is not associated with an increased risk of postoperative bleeding in children undergoing tonsillectomy.

Eligible Conditions
  • Tonsillar Bleeding
  • Postoperative Nausea and Vomiting
  • Postoperative Pain

Blueberry Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 intervals: 0-2 hours, 2-6 hours and 6-24 hours postoperatively
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 intervals: 0-2 hours, 2-6 hours and 6-24 hours postoperatively for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reoperation for postoperative bleeding
Secondary outcome measures
Morbidity
Pain scores
Postoperative nausea, vomiting and retching
+1 more

Side effects data

From 2013 Phase 4 trial • 122 Patients • NCT01474915
2%
Deep Vein Thrombosis
2%
Cerebrospinal fluid leak
2%
Fever
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ondansetron
Aprepitant

Blueberry Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: DexamethasoneExperimental Treatment1 Intervention
Single intraoperative administration of 0.15 mg/kg of Dexamethasone intravenously with a maximum dose of 5 mg
Group II: Sodium chloridePlacebo Group1 Intervention
Single intraoperative administration of Sodium Chloride (NaCl) 0.9% intravenously
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dexamethasone
FDA approved

Find a Location

Who is running the clinical trial?

University Hospital, GenevaOTHER
488 Previous Clinical Trials
1,858,778 Total Patients Enrolled
Walid HABRELead Sponsor
6 Previous Clinical Trials
180 Total Patients Enrolled

Media Library

Dexamethasone (Corticosteroid) Clinical Trial Eligibility Overview. Trial Name: NCT04188431 — Phase 4
Tonsillar Bleeding Research Study Groups: Sodium chloride, Dexamethasone
Tonsillar Bleeding Clinical Trial 2023: Dexamethasone Highlights & Side Effects. Trial Name: NCT04188431 — Phase 4
Dexamethasone (Corticosteroid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04188431 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What conditions are commonly alleviated with Dexamethasone?

"To combat elevated intra ocular pressure (iop), Dexamethasone is often prescribed. This medication can also be used to help patients manage symptoms related to ophthalmia, sympathetic inflammation, nasal irritation, and branch retinal vein occlusion."

Answered by AI

How many individuals have been recruited for this research project?

"Indeed, the clinicaltrials.gov page for this trial confirms that it is actively seeking participants; first posted on November 1st 2020 and last updated on September 30th 2021, with a patient recruitment goal of 3794 across one site."

Answered by AI

What other trials have utilized Dexamethasone to examine outcomes?

"Presently, 650 studies are being conducted regarding the medical efficacy of Dexamethasone. Of those active trials, 168 have reached Phase 3 testing. The majority of these research projects take place in Mishawaka, Indiana yet there are 19,031 other locations around the world also running such experiments."

Answered by AI

What are the eligibility criteria for participation in this clinical experiment?

"In a trial of 3794 children aged from 2 to 13, those who have experienced postoperative pain are eligible for admission. Additional criteria that must be met include having had a tonsillectomy/tonsillotomy with or without adenoidectomy."

Answered by AI

Is the participant age limit in this trial greater than twenty years?

"This medical study can accept patients that are between 2 and 13 years of age. A total of 230 studies have been conducted on minors and 1284 trials for seniors over the age 65."

Answered by AI

Is there currently an opportunity available to join this research?

"Affirmative. Clinicaltrials.gov data confirms that the study, which was originally posted on November 1st 2020, is recruiting participants at present. The requirements are 3794 individuals from a single medical centre."

Answered by AI

What potential ill effects could Dexamethasone pose for individuals?

"The safety rating of Dexamethasone stands at 3 due to the fact it has been approved by a phase 4 trial, thus having obtained adequate data demonstrating its efficacy."

Answered by AI
~859 spots leftby Apr 2025